GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma

Authors :: Clement, P. (Patricia)
Booth, T. (Thomas)
Borovecki, F. (Fran)
Emblem, K.E. (Kyrre E.)
Figueiredo, P. (Patrícia)
Hirschler, L. (Lydiane)
Jančálek, R. (Radim)
Keil, V.C. (Vera C.)
Maumet, C. (Camille)
Özsunar, Y. (Yelda)
Pernet, C. (Cyril)
Petr, J. (Jan)
Pinto, J. (Joana)
Smits, M. (Marion)
Warnert, E.A.H. (Esther A. H.)
Clement, P. (Patricia)
Booth, T. (Thomas)
Borovecki, F. (Fran)
Emblem, K.E. (Kyrre E.)
Figueiredo, P. (Patrícia)
Hirschler, L. (Lydiane)
Jančálek, R. (Radim)
Keil, V.C. (Vera C.)
Maumet, C. (Camille)
Özsunar, Y. (Yelda)
Pernet, C. (Cyril)
Petr, J. (Jan)
Pinto, J. (Joana)
Smits, M. (Marion)
Warnert, E.A.H. (Esther A. H.)
Publication Year :: 2020
Abstract: Purpose: There is an annual incidence of 50,000 glioma cases in Europe. The optimal treatment strategy is highly personalised, depending on tumour type, grade, spatial localization, and the degree of tissue infiltration. In research settings, advanced magnetic resonance imaging (MRI) has shown great promise as a tool to inform personalised treatment decisions. However, the use of advanced MRI in clinical practice rema

Database :: OAIster
Notes :: application/pdf, Journal of Medical and Biological Engineering, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1244873868
Document Type :: Electronic Resource
Full Text :: https://doi.org/10.1007.s40846-020-00582-z

Full Text Access

Tools